900 |
Marathi |
Beneficiary Registration |
|
|
Awele |
Abhimanyu |
1 month 3 weeks |
900 |
Telugu |
Beneficiary Registration |
|
|
Awele |
Abhimanyu |
1 month 3 weeks |
901 |
English |
Benefits Processing in Nikshay |
Published on LMS |
Link |
AmalS |
PrashantBhat |
1 month 2 weeks |
901 |
Marathi |
Benefits Processing in Nikshay |
Published on LMS |
|
AmalS |
PrashantBhat |
1 month 2 weeks |
901 |
Telugu |
Benefits Processing in Nikshay |
Published on LMS |
|
AmalS |
PrashantBhat |
1 month 2 weeks |
939 |
English |
Incentive For Notification and Outcome Declaration |
Published on LMS |
Link |
RichardS |
Abhimanyu |
1 month 2 weeks |
939 |
Marathi |
Incentive For Notification and Outcome Declaration |
Published on LMS |
|
RichardS |
Abhimanyu |
1 month 2 weeks |
939 |
Telugu |
Incentive For Notification and Outcome Declaration |
Published on LMS |
|
RichardS |
Abhimanyu |
1 month 2 weeks |
902 |
English |
Action by DBT Maker/Checker in Nikshay interface |
Under Development |
Link |
Awele |
Abhimanyu |
1 month 2 weeks |
902 |
Marathi |
Action by DBT Maker/Checker in Nikshay interface |
Published on LMS |
|
Awele |
Abhimanyu |
1 month 2 weeks |
902 |
Telugu |
Action by DBT Maker/Checker in Nikshay interface |
Under Development |
|
Awele |
Abhimanyu |
1 month 2 weeks |
1003 |
English |
Management of DR-TB ADR: Hematological Abnormalities |
Page Prioritised |
Link |
Archana.Singh |
Abhimanyu |
1 month 2 weeks |
1004 |
English |
Management of DR-TB ADR: Hypothyroidism |
Page Prioritised |
Link |
Archana.Singh |
Abhimanyu |
1 month 2 weeks |
1005 |
English |
Management of DR-TB ADR: Arthralgia |
Page Prioritised |
Link |
Awele |
Abhimanyu |
1 month 2 weeks |
1007 |
English |
Management of DR-TB ADR: Psychotic Symptoms |
Final Review |
Link |
Dr. Priyadarshini |
Abhimanyu |
1 month 2 weeks |
1010 |
English |
Management of DR-TB ADR: Nephrotoxicity [Renal Toxicity] |
Page Prioritised |
Link |
Dr. Priyadarshini |
Abhimanyu |
1 month 2 weeks |
1011 |
English |
Management of DR-TB ADR: Gynecomastia |
Final Review |
Link |
NimishaArora |
Abhimanyu |
1 month 2 weeks |
1032 |
English |
Delamanid [Dlm] Drug Dosages and Duration |
Page Prioritised |
Link |
NimishaArora |
Abhimanyu |
1 month 2 weeks |
1075 |
English |
Drug-resistant TB Service Linkages to Private Sectors |
Page Prioritised |
Link |
Awele |
Abhimanyu |
1 month 2 weeks |
1122 |
English |
Follow-up Monitoring for individuals taking TPT |
Approved |
Link |
Dr. Priyadarshini |
Abhimanyu |
1 month 2 weeks |
1126 |
English |
Newer Anti-TB Drugs: Bedaquiline [Bdq] |
Final Review |
Link |
NimishaArora |
Abhimanyu |
1 month 2 weeks |
1128 |
English |
Newer Anti-TB Drugs: Delamanid [Dlm] |
Page Prioritised |
Link |
Archana.Singh |
Abhimanyu |
1 month 2 weeks |
1129 |
English |
Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Pre-treatment Evaluation [PTE] |
Approved |
Link |
Archana.Singh |
Abhimanyu |
1 month 2 weeks |
1130 |
English |
Causes for Drug-resistant Tuberculosis |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
1 month 2 weeks |
1132 |
English |
Baseline Second-line Drug-susceptibility Testing |
Page Prioritised |
Link |
NimishaArora |
Abhimanyu |
1 month 2 weeks |
1133 |
English |
Prevention of Drug-resistance |
Final Review |
Link |
NimishaArora |
Abhimanyu |
1 month 2 weeks |
1136 |
English |
Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Eligibility Criteria |
Approved |
Link |
Archana.Singh |
Abhimanyu |
1 month 2 weeks |
1137 |
English |
Requirements from Institutions for the Establishment of Nodal DR-TB Centre |
Final Review |
Link |
NimishaArora |
Abhimanyu |
1 month 2 weeks |
1138 |
English |
DR-TB Services Referral Linkage Scenario: Patient Notified from the Private Sector |
Approved |
Link |
Awele |
Abhimanyu |
1 month 2 weeks |
1140 |
English |
DR-TB Service Referral Linkages Scenario: DR-TB Patient Referred for Treatment from the Private Sector with Treatment Initiated in the Private Sector |
Approved |
Link |
Archana.Singh |
Abhimanyu |
1 month 2 weeks |
1139 |
English |
DR-TB Service Referral Linkages Scenario: DR-TB Patient Referred for Treatment from the Private Sector with Bacteriological Confirmation in the Private Sector |
Approved |
Link |
Awele |
Abhimanyu |
1 month 2 weeks |
1162 |
English |
Quality Assurance of Anti-TB Drugs |
Final Review |
Link |
NimishaArora |
Abhimanyu |
1 month 2 weeks |
1163 |
English |
Universal Access to Quality TB Care |
Final Review |
Link |
NimishaArora |
Abhimanyu |
1 month 2 weeks |
1164 |
English |
End TB Strategy Approach |
Final Review |
Link |
NimishaArora |
Abhimanyu |
1 month 2 weeks |
1165 |
English |
Functions of District National Health Mission |
Final Review |
Link |
NimishaArora |
Abhimanyu |
1 month 2 weeks |
1167 |
English |
Roles of Accredited Social Health Activist [ASHA] for TB Service Delivery at ABHWCs |
Final Review |
Link |
NimishaArora |
Abhimanyu |
1 month 2 weeks |
1168 |
English |
Recording and Reporting at Ayushman Bharat Health and Wellness Centres |
Final Review |
Link |
NimishaArora |
Abhimanyu |
1 month 2 weeks |
1169 |
English |
Patient Provider Support Agency [PPSA]: A Multipronged Approach to Engage the Private Sector |
Approved |
Link |
RichardS |
Abhimanyu |
1 month 2 weeks |
1169 |
Marathi |
Patient Provider Support Agency [PPSA]: A Multipronged Approach to Engage the Private Sector |
Approved |
|
RichardS |
Abhimanyu |
1 month 2 weeks |
1169 |
Telugu |
Patient Provider Support Agency [PPSA]: A Multipronged Approach to Engage the Private Sector |
Approved |
|
RichardS |
Abhimanyu |
1 month 2 weeks |
1170 |
English |
Importance of Properly Identifying Presumptive TB Cases |
Final Review |
Link |
NimishaArora |
Abhimanyu |
1 month 2 weeks |
1171 |
English |
Aims and Objectives of Screening for Active TB |
Page Prioritised |
Link |
NimishaArora |
Abhimanyu |
1 month 2 weeks |
1172 |
English |
Precautions to Ensure Reliability of a Test for Diagnosis of DR-TB |
Final Review |
Link |
NimishaArora |
Abhimanyu |
1 month 2 weeks |
1180 |
English |
Direct Benefits Transfer [DBT] Module: Nikshay Poshan Yojana [NPY] |
Final Review |
Link |
NimishaArora |
Abhimanyu |
1 month 2 weeks |
1184 |
English |
SWOT Analysis of NTEP as per NSP 2020-25 |
Final Review |
Link |
NimishaArora |
Abhimanyu |
1 month 2 weeks |
1190 |
English |
Drugs, Consumables and Financial Support at Ayushman Bharat Health and Wellness Centres |
Page Prioritised |
Link |
NimishaArora |
Abhimanyu |
1 month 2 weeks |
1192 |
English |
Types of Health Facilities in the Private Sector: Private Labs |
Final Review |
Link |
Awele |
Abhimanyu |
1 month 2 weeks |
1192 |
Marathi |
Types of Health Facilities in the Private Sector: Private Labs |
Final Review |
|
Awele |
Abhimanyu |
1 month 2 weeks |
1192 |
Telugu |
Types of Health Facilities in the Private Sector: Private Labs |
Final Review |
|
Awele |
Abhimanyu |
1 month 2 weeks |
1199 |
English |
Vulnerable Population Mapping for TB Screening |
Final Review |
Link |
NimishaArora |
Abhimanyu |
1 month 2 weeks |